These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6027604)

  • 1. Effect of dosage and influenza vaccine content on antibody response in medical students.
    Saslaw S; Carlisle HN; Perkins RL
    Am J Med Sci; 1967 Jun; 253(6):710-7. PubMed ID: 6027604
    [No Abstract]   [Full Text] [Related]  

  • 2. EFFECT OF DOSAGE ON ANTIBODY RESPONSE TO POLYVALENT INFLUENZA VIRUS VACCINE IN AN AGED POPULATION.
    SASLAW S; CARLISLE HN
    Am J Med Sci; 1964 Sep; 248():273-84. PubMed ID: 14210303
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental comparison of intradermal and subcutaneous vaccination with influenza vaccine.
    Crowe AE
    Am J Med Technol; 1965; 31(6):387-96. PubMed ID: 5319699
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
    Závadová H; Adam E; Vonka V; Domorázková E; Kratochvílová M; Burian V; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):53-61. PubMed ID: 5062439
    [No Abstract]   [Full Text] [Related]  

  • 6. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity.
    Ruben FL; Jackson GG
    J Infect Dis; 1972 Jun; 125(6):656-64. PubMed ID: 4556572
    [No Abstract]   [Full Text] [Related]  

  • 7. Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization.
    Phillips CA; Forsyth BR; Christmas WA; Gump DW; Whorton EB; Rogers I; Rudin A
    J Infect Dis; 1970; 122(1):26-32. PubMed ID: 5433710
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man.
    Tauraso NM; Gleckman R; Pedreira FA; Sabbaj J; Yahwak R; Madoff MA
    Bull World Health Organ; 1969; 41(3):507-16. PubMed ID: 5309465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
    Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Intradermal influenza vaccination.
    Payler DK; Skirrow MB
    Br Med J; 1974 Jun; 2(5921):727. PubMed ID: 4852830
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to intradermal vaccination with A2, Hong Kong variant, influenza vaccine.
    McElroy JT; Szwed JJ
    N Engl J Med; 1969 Nov; 281(19):1076. PubMed ID: 5343531
    [No Abstract]   [Full Text] [Related]  

  • 12. A new subunit influenza vaccine; acceptability compared with standard vaccines and antigenicity in increasing dosage.
    Ruben FL; Jackson GG
    Postgrad Med J; 1973 Mar; 49(569):185-92. PubMed ID: 4802372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Influenza vaccination.
    Avison J
    Br Med J; 1973 Nov; 4(5888):358. PubMed ID: 4758436
    [No Abstract]   [Full Text] [Related]  

  • 14. Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination.
    Wenzel RP; Hendley JO; Sande MA; Gwaltney JM
    JAMA; 1973 Oct; 226(4):435-8. PubMed ID: 4800234
    [No Abstract]   [Full Text] [Related]  

  • 15. Intradermal influenza immunization. Experience with Hong Kong vaccine.
    Marks MI; Eller JJ
    Am Rev Respir Dis; 1971 Apr; 103(4):579-81. PubMed ID: 5550353
    [No Abstract]   [Full Text] [Related]  

  • 16. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiinfluenzal vaccination with aerosol administration in subjects belonging to a closed community].
    Zardi O; Gabrielli G; Adorisio E; Lolli C; Lancetta A
    Nuovi Ann Ig Microbiol; 1971; 22(4):243-54. PubMed ID: 5146065
    [No Abstract]   [Full Text] [Related]  

  • 19. Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults.
    Nougarede N; Bisceglia H; Rozières A; Goujon C; Boudet F; Laurent P; Vanbervliet B; Rodet K; Hennino A; Nicolas JF
    Hum Vaccin Immunother; 2014; 10(9):2713-20. PubMed ID: 25483667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
    Gorse GJ; Falsey AR; Fling JA; Poling TL; Strout CB; Tsang PH
    Vaccine; 2013 May; 31(19):2358-65. PubMed ID: 23499604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.